Inovio initiates Phase I trial of its Ebola DNA immunotherapy
12 May 2015 | By Victoria White
Inovio Pharmaceuticals has initiated a Phase I trial to evaluate safety, tolerability and immune responses of its Ebola DNA immunotherapy...
List view / Grid view
12 May 2015 | By Victoria White
Inovio Pharmaceuticals has initiated a Phase I trial to evaluate safety, tolerability and immune responses of its Ebola DNA immunotherapy...
12 May 2015 | By Victoria White
Takeda has announced that the first patient has been enrolled in the Phase 3 TOURMALINE-MM4 study of investigational oral ixazomib...
12 May 2015 | By Victoria White
The number of strokes occurring in men aged between 40 and 54 has rocketed by almost 50% in less than 15 years, according to the Stroke Association...
12 May 2015 | By Victoria White
GW Pharmaceuticals has commenced a Phase 3 clinical trial of Epidiolex (cannabidiol or CBD) for the treatment of Lennox-Gastaut syndrome (LGS)...
12 May 2015 | By Victoria White
Pfizer has acquired a minority equity interest in AM-Pharma and secured an exclusive option to acquire the remaining equity in the company...
11 May 2015 | By Victoria White
Data from a post-hoc analysis of a Phase 3a trial demonstrates the weight-loss-dependent and independent effects of liraglutide 3 mg...
11 May 2015 | By Victoria White
SMC has accepted seven new medicines for use in NHS Scotland. Two of these medicines, Azerra and Zydelig, were considered under SMC’s PACE process...
11 May 2015 | By Victoria White
Boyds has joined CTD Holdings’ Clinical Programme Team along with Aptus Clinical and KJC Statistics to develop orphan drug Trappsol Cyclo with Accenture...
11 May 2015 | By Victoria White
The FDA has approved Avelox in the US to treat patients with plague, including pneumonic plague and septicemic plague...
11 May 2015 | By Victoria White
Transition Therapeutics has exclusively licensed worldwide rights to a novel small molecule drug candidate, TT701, from Eli Lilly and Company...
11 May 2015 | By Victoria White
WHO has declared Liberia free of Ebola transmission - forty-two days have passed since the last laboratory-confirmed case was buried...
11 May 2015 | By Victoria White
Roche has announced that data from 10 of its approved cancer medicines and 10 of its investigational medicines will be presented at this year’s American Society of Clinical Oncology Annual Meeting (ASCO 2015).
8 May 2015 | By Victoria White
WHO has called on scientists, national authorities and the media to follow best practices for disease names to minimise unnecessary negative effects...
8 May 2015 | By
The FDA has lifted the clinical hold on clinical studies of ND0612H and ND0612L, NeuroDerm's product candidates for the treatment of Parkinson’s disease...
8 May 2015 | By Victoria White
The FDA has granted Fast Track Designation for cobiprostone, a locally acting chloride channel activator, for the prevention of oral mucositis.